Rapid Detection of Group B Strep- 35-37 Week Study
NCT00331019 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2015-12-15
Summary
The purpose of this study is to determine whether a rapid bedside diagnosis of Group B Strep growing in the vagina and rectum can be performed with similar success to the routine culture.
Conditions
- Group B Streptococcus Neonatal Sepsis
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Mark D Pearlman, MD · University of Michigan, Obstetrics & Gynecology
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-07-31
- Primary Completion
- 2006-07-31
Countries
- United States
Study Locations
More Related Trials
-
Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor
NCT02511444 ·Status: COMPLETED ·Phase: NA
-
Streptococcal Infection and Respiratory Distress in Newborns
NCT00612937 ·Status: COMPLETED
-
Developing a Controlled Human Infection Model for Group B Streptococcus (CHIM_GBS)
NCT04059510 ·Status: UNKNOWN
-
Integrative Approach to Identify Environmental Risk Factors for CC-17 Group B Streptococcal Neonatal Infection
NCT02471937 ·Status: COMPLETED ·Phase: NA
-
Group B Streptococcus (GBS) Polymerase Chain Reaction (PCR) Concordance Study
NCT00972894 ·Status: UNKNOWN
-
Simplified GBS Screening and Prevalence of ESBL in Pregnant Women
NCT02142933 ·Status: COMPLETED ·Phase: NA
-
Group B Streptococcus Infection and PROM Incidince
NCT06735703 ·Status: NOT_YET_RECRUITING
-
CCA of SGB PCR Versus SGB Culture at 35-38 SA in the Optimization of Intrapartum Antibiotic Prophylaxis
NCT05005169 ·Status: COMPLETED ·Phase: NA
-
MATERNAL AND NEONATAL SCREENING FOR GROUP B STREPTOCOCCI : A Follow up STUDY
NCT04227730 ·Status: WITHDRAWN
-
Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics
NCT02527681 ·Status: TERMINATED ·Phase: PHASE1
-
Serial Screening and Treatment of Bacterial Vaginosis Trial
NCT05278130 ·Status: WITHDRAWN ·Phase: NA
-
Maternal- Fetal Infection
NCT03371056 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of the ARIES Group B Streptococcus (GBS) Assay
NCT02497430 ·Status: COMPLETED
-
Feasibility Study for Identifying Anti Capsular Antibody Protection Against Invasive Group B Streptococcus (GBS) Disease in Newborns of 0-6 Days Age (Early Onset Disease [EOD]) as Well as Among Infants of 7-90 Days Age (Late Onset Disease [LOD])
NCT01888471 ·Status: COMPLETED ·Phase: NA
-
Clinical Utility of Rapid CT/NG Testing in the ED
NCT02200224 ·Status: COMPLETED ·Phase: NA
-
Inflammation and Treatment of Bacterial Vaginosis Near Term
NCT00720291 ·Status: COMPLETED ·Phase: NA
-
Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences
NCT04955717 ·Status: COMPLETED ·Phase: NA
-
Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings
NCT01446289 ·Status: COMPLETED ·Phase: PHASE2
-
Group A Streptococcus Saliva Study
NCT06473506 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Molecular Culture for the Diagnosis of Neonatal Sepsis
NCT05763680 ·Status: UNKNOWN
-
Assessment of Assay for Rapid Identification of Bloodstream Infections From Whole Blood
NCT04147975 ·Status: UNKNOWN
-
Interest of the Detection of Hyper-virulent Clone ST17 of Group B Strep (GBS) for the Prevention of Neonatal GBS Meningitis
NCT01719510 ·Status: COMPLETED ·Phase: NA
-
A Prospective Cohort Pilot Study of the Clinical and Molecular Epidemiology of Staphylococcus Aureus in Pregnant Women at the Time of Group B Streptococcal Screening in a Large Urban Medical Center in Chicago, IL USA
NCT00532324 ·Status: COMPLETED ·Phase: NA
-
Point-Of-Care Testing for Congenital Syphilis in Mothers and Newborns
NCT03814096 ·Status: WITHDRAWN ·Phase: NA
-
Carriage of Beta Haemolytic Streptococci During Pregnancy
NCT05365711 ·Status: ACTIVE_NOT_RECRUITING